Andrographolide - Explore the Science & Experts | ideXlab


Scan Science and Technology

Contact Leading Edge Experts & Companies

Andrographolide

The Experts below are selected from a list of 5988 Experts worldwide ranked by ideXlab platform

Andrographolide – Free Register to Access Experts & Abstracts

Nikolaus J Sucher – One of the best experts on this subject based on the ideXlab platform.

  • an in vitro study of anti inflammatory activity of standardised andrographis paniculata extracts and pure Andrographolide
    BMC Complementary and Alternative Medicine, 2015
    Co-Authors: Mitchell Low, Cheang S Khoo, Gerald Munch, Suresh Govindaraghavan, Nikolaus J Sucher

    Abstract:

    The anti-inflammatory activity of Andrographis paniculata (Acanthaceae), a traditional medicine widely used in Asia, is commonly attributed to Andrographolide, its main secondary metabolite. Commercial A. paniculata extracts are standardised to Andrographolide content. We undertook the present study to investigate 1) how selective enrichment of Andrographolide in commercial A. paniculata extracts affects the variability of non-standardised phytochemical components and 2) if variability in the non-standardised components of the extract affects the pharmacological activity of Andrographolide itself. We characterized 12 commercial, standardised (≥30% Andrographolide) batches of A. paniculata extracts from India by HPLC profiling. We determined the antioxidant capacity of the extracts using 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging, oxygen radical antioxidant capacity (ORAC) and a Folin-Ciocalteu (FC) antioxidant assays. Their anti-inflammatory activity was assessed by assaying their inhibitory effect on the release of tumor necrosis factor alpha (TNF-α) in the human monocytic cell line THP-1. The Andrographolide content in the samples was close to the claimed value (32.2 ± 2.1%, range 27.5 to 35.9%). Twenty-one non-standardised constituents exhibited more than 2-fold variation in HPLC peak intensities in the tested batches. The chlorogenic acid content of the batches varied more than 30-fold. The DPPH free radical scavenging activity varied ~3-fold, the ORAC and FC antioxidant capacity varied ~1.5 fold among batches. In contrast, the TNF-α inhibitory activity of the extracts exhibited little variation and comparison with pure Andrographolide indicated that it was mostly due to their Andrographolide content. Standardised A. paniculata extracts contained the claimed amount of Andrographolide but exhibited considerable phytochemical background variation. DPPH radical scavenging activity of the extracts was mostly due to the flavonoid/phenlycarboxylic acid compounds in the extracts. The inhibitory effect of Andrographolide on the release of TNF-α was little affected by the quantitative variation of the non-standardised constituents.

    Free Register to Access Article

  • An in vitro study of anti-inflammatory activity of standardised Andrographis paniculata extracts and pure Andrographolide
    BMC Complementary and Alternative Medicine, 2015
    Co-Authors: Cheang S Khoo, Gerald Munch, Suresh Govindaraghavan, Nikolaus J Sucher

    Abstract:

    Background The anti-inflammatory activity of Andrographis paniculata (Acanthaceae), a traditional medicine widely used in Asia, is commonly attributed to Andrographolide, its main secondary metabolite. Commercial A. paniculata extracts are standardised to Andrographolide content. We undertook the present study to investigate 1) how selective enrichment of Andrographolide in commercial A. paniculata extracts affects the variability of non-standardised phytochemical components and 2) if variability in the non-standardised components of the extract affects the pharmacological activity of Andrographolide itself. Methods We characterized 12 commercial, standardised (≥30% Andrographolide) batches of A. paniculata extracts from India by HPLC profiling. We determined the antioxidant capacity of the extracts using 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging, oxygen radical antioxidant capacity (ORAC) and a Folin-Ciocalteu (FC) antioxidant assays. Their anti-inflammatory activity was assessed by assaying their inhibitory effect on the release of tumor necrosis factor alpha (TNF-α) in the human monocytic cell line THP-1. Results The Andrographolide content in the samples was close to the claimed value (32.2 ± 2.1%, range 27.5 to 35.9%). Twenty-one non-standardised constituents exhibited more than 2-fold variation in HPLC peak intensities in the tested batches. The chlorogenic acid content of the batches varied more than 30-fold. The DPPH free radical scavenging activity varied ~3-fold, the ORAC and FC antioxidant capacity varied ~1.5 fold among batches. In contrast, the TNF-α inhibitory activity of the extracts exhibited little variation and comparison with pure Andrographolide indicated that it was mostly due to their Andrographolide content. Conclusions Standardised A. paniculata extracts contained the claimed amount of Andrographolide but exhibited considerable phytochemical background variation. DPPH radical scavenging activity of the extracts was mostly due to the flavonoid/phenlycarboxylic acid compounds in the extracts. The inhibitory effect of Andrographolide on the release of TNF-α was little affected by the quantitative variation of the non-standardised constituents.

    Free Register to Access Article

Cheang S Khoo – One of the best experts on this subject based on the ideXlab platform.

  • an in vitro study of anti inflammatory activity of standardised andrographis paniculata extracts and pure Andrographolide
    BMC Complementary and Alternative Medicine, 2015
    Co-Authors: Mitchell Low, Cheang S Khoo, Gerald Munch, Suresh Govindaraghavan, Nikolaus J Sucher

    Abstract:

    The anti-inflammatory activity of Andrographis paniculata (Acanthaceae), a traditional medicine widely used in Asia, is commonly attributed to Andrographolide, its main secondary metabolite. Commercial A. paniculata extracts are standardised to Andrographolide content. We undertook the present study to investigate 1) how selective enrichment of Andrographolide in commercial A. paniculata extracts affects the variability of non-standardised phytochemical components and 2) if variability in the non-standardised components of the extract affects the pharmacological activity of Andrographolide itself. We characterized 12 commercial, standardised (≥30% Andrographolide) batches of A. paniculata extracts from India by HPLC profiling. We determined the antioxidant capacity of the extracts using 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging, oxygen radical antioxidant capacity (ORAC) and a Folin-Ciocalteu (FC) antioxidant assays. Their anti-inflammatory activity was assessed by assaying their inhibitory effect on the release of tumor necrosis factor alpha (TNF-α) in the human monocytic cell line THP-1. The Andrographolide content in the samples was close to the claimed value (32.2 ± 2.1%, range 27.5 to 35.9%). Twenty-one non-standardised constituents exhibited more than 2-fold variation in HPLC peak intensities in the tested batches. The chlorogenic acid content of the batches varied more than 30-fold. The DPPH free radical scavenging activity varied ~3-fold, the ORAC and FC antioxidant capacity varied ~1.5 fold among batches. In contrast, the TNF-α inhibitory activity of the extracts exhibited little variation and comparison with pure Andrographolide indicated that it was mostly due to their Andrographolide content. Standardised A. paniculata extracts contained the claimed amount of Andrographolide but exhibited considerable phytochemical background variation. DPPH radical scavenging activity of the extracts was mostly due to the flavonoid/phenlycarboxylic acid compounds in the extracts. The inhibitory effect of Andrographolide on the release of TNF-α was little affected by the quantitative variation of the non-standardised constituents.

    Free Register to Access Article

  • An in vitro study of anti-inflammatory activity of standardised Andrographis paniculata extracts and pure Andrographolide
    BMC Complementary and Alternative Medicine, 2015
    Co-Authors: Cheang S Khoo, Gerald Munch, Suresh Govindaraghavan, Nikolaus J Sucher

    Abstract:

    Background The anti-inflammatory activity of Andrographis paniculata (Acanthaceae), a traditional medicine widely used in Asia, is commonly attributed to Andrographolide, its main secondary metabolite. Commercial A. paniculata extracts are standardised to Andrographolide content. We undertook the present study to investigate 1) how selective enrichment of Andrographolide in commercial A. paniculata extracts affects the variability of non-standardised phytochemical components and 2) if variability in the non-standardised components of the extract affects the pharmacological activity of Andrographolide itself. Methods We characterized 12 commercial, standardised (≥30% Andrographolide) batches of A. paniculata extracts from India by HPLC profiling. We determined the antioxidant capacity of the extracts using 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging, oxygen radical antioxidant capacity (ORAC) and a Folin-Ciocalteu (FC) antioxidant assays. Their anti-inflammatory activity was assessed by assaying their inhibitory effect on the release of tumor necrosis factor alpha (TNF-α) in the human monocytic cell line THP-1. Results The Andrographolide content in the samples was close to the claimed value (32.2 ± 2.1%, range 27.5 to 35.9%). Twenty-one non-standardised constituents exhibited more than 2-fold variation in HPLC peak intensities in the tested batches. The chlorogenic acid content of the batches varied more than 30-fold. The DPPH free radical scavenging activity varied ~3-fold, the ORAC and FC antioxidant capacity varied ~1.5 fold among batches. In contrast, the TNF-α inhibitory activity of the extracts exhibited little variation and comparison with pure Andrographolide indicated that it was mostly due to their Andrographolide content. Conclusions Standardised A. paniculata extracts contained the claimed amount of Andrographolide but exhibited considerable phytochemical background variation. DPPH radical scavenging activity of the extracts was mostly due to the flavonoid/phenlycarboxylic acid compounds in the extracts. The inhibitory effect of Andrographolide on the release of TNF-α was little affected by the quantitative variation of the non-standardised constituents.

    Free Register to Access Article

Suresh Govindaraghavan – One of the best experts on this subject based on the ideXlab platform.

  • an in vitro study of anti inflammatory activity of standardised andrographis paniculata extracts and pure Andrographolide
    BMC Complementary and Alternative Medicine, 2015
    Co-Authors: Mitchell Low, Cheang S Khoo, Gerald Munch, Suresh Govindaraghavan, Nikolaus J Sucher

    Abstract:

    The anti-inflammatory activity of Andrographis paniculata (Acanthaceae), a traditional medicine widely used in Asia, is commonly attributed to Andrographolide, its main secondary metabolite. Commercial A. paniculata extracts are standardised to Andrographolide content. We undertook the present study to investigate 1) how selective enrichment of Andrographolide in commercial A. paniculata extracts affects the variability of non-standardised phytochemical components and 2) if variability in the non-standardised components of the extract affects the pharmacological activity of Andrographolide itself. We characterized 12 commercial, standardised (≥30% Andrographolide) batches of A. paniculata extracts from India by HPLC profiling. We determined the antioxidant capacity of the extracts using 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging, oxygen radical antioxidant capacity (ORAC) and a Folin-Ciocalteu (FC) antioxidant assays. Their anti-inflammatory activity was assessed by assaying their inhibitory effect on the release of tumor necrosis factor alpha (TNF-α) in the human monocytic cell line THP-1. The Andrographolide content in the samples was close to the claimed value (32.2 ± 2.1%, range 27.5 to 35.9%). Twenty-one non-standardised constituents exhibited more than 2-fold variation in HPLC peak intensities in the tested batches. The chlorogenic acid content of the batches varied more than 30-fold. The DPPH free radical scavenging activity varied ~3-fold, the ORAC and FC antioxidant capacity varied ~1.5 fold among batches. In contrast, the TNF-α inhibitory activity of the extracts exhibited little variation and comparison with pure Andrographolide indicated that it was mostly due to their Andrographolide content. Standardised A. paniculata extracts contained the claimed amount of Andrographolide but exhibited considerable phytochemical background variation. DPPH radical scavenging activity of the extracts was mostly due to the flavonoid/phenlycarboxylic acid compounds in the extracts. The inhibitory effect of Andrographolide on the release of TNF-α was little affected by the quantitative variation of the non-standardised constituents.

    Free Register to Access Article

  • An in vitro study of anti-inflammatory activity of standardised Andrographis paniculata extracts and pure Andrographolide
    BMC Complementary and Alternative Medicine, 2015
    Co-Authors: Cheang S Khoo, Gerald Munch, Suresh Govindaraghavan, Nikolaus J Sucher

    Abstract:

    Background The anti-inflammatory activity of Andrographis paniculata (Acanthaceae), a traditional medicine widely used in Asia, is commonly attributed to Andrographolide, its main secondary metabolite. Commercial A. paniculata extracts are standardised to Andrographolide content. We undertook the present study to investigate 1) how selective enrichment of Andrographolide in commercial A. paniculata extracts affects the variability of non-standardised phytochemical components and 2) if variability in the non-standardised components of the extract affects the pharmacological activity of Andrographolide itself. Methods We characterized 12 commercial, standardised (≥30% Andrographolide) batches of A. paniculata extracts from India by HPLC profiling. We determined the antioxidant capacity of the extracts using 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging, oxygen radical antioxidant capacity (ORAC) and a Folin-Ciocalteu (FC) antioxidant assays. Their anti-inflammatory activity was assessed by assaying their inhibitory effect on the release of tumor necrosis factor alpha (TNF-α) in the human monocytic cell line THP-1. Results The Andrographolide content in the samples was close to the claimed value (32.2 ± 2.1%, range 27.5 to 35.9%). Twenty-one non-standardised constituents exhibited more than 2-fold variation in HPLC peak intensities in the tested batches. The chlorogenic acid content of the batches varied more than 30-fold. The DPPH free radical scavenging activity varied ~3-fold, the ORAC and FC antioxidant capacity varied ~1.5 fold among batches. In contrast, the TNF-α inhibitory activity of the extracts exhibited little variation and comparison with pure Andrographolide indicated that it was mostly due to their Andrographolide content. Conclusions Standardised A. paniculata extracts contained the claimed amount of Andrographolide but exhibited considerable phytochemical background variation. DPPH radical scavenging activity of the extracts was mostly due to the flavonoid/phenlycarboxylic acid compounds in the extracts. The inhibitory effect of Andrographolide on the release of TNF-α was little affected by the quantitative variation of the non-standardised constituents.

    Free Register to Access Article